Advanced Heart Failure Comprehensive Care Center
Each year, UCSF's Advanced Heart Failure Comprehensive Care Center (AHF CCC) treats and evaluates between 250 and 300 patients for heart failure. We are recognized internationally for our expertise in diagnosing and treating advanced heart failure.
We use remote monitoring to closely track our patients' status and provide state-of-the-art conventional and experimental drug and device therapies. Working with a broad team of heart specialists, we provide seamless coordinated care for our heart failure patients. Depending on the cause of the heart failure, treatment may include:
- Medication
- Heart pumps
- Ventricular assist devices
- Coronary artery bypass grafting and valve surgery
- Percutaneous coronary interventions such as angioplasty
If those therapies aren't successful, a heart transplant may be an option. Since 1989, the AHF CCC has performed nearly 600 heart transplants. We are the sixth largest heart transplant program in the nation and continue to grow rapidly.
We are constantly exploring new technologies that allow us to accept donor hearts that could not have been accepted in the past. This innovative approach means that we have access to more donor hearts and are able to reduce waitlist times for patients requiring a heart transplant.
As a national leader in advanced heart failure care we are dedicated to finding new effective therapies. Eligible patients may be able to take part in clinical trials for heart failure treatment. Learn more about the process and benefits of participating in a clinical trial.
Doctor referral required
Our locations (3)
Our team
Awards & recognition
-
Among the top hospitals in the nation
-
One of the nation's best for heart & vascular surgery
-
Rated high-performing hospital for heart bypass surgery
-
Rated high-performing hospital for heart failure
Clinical trials
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least...
Freedom from a composite of major adverse events (defined as Device Embolization, Vessel Erosion, Cardiac Perforation, and occurrence of cardiac surgery or percutaneous coronary intervention) in the Intervention group is greater t...
Recruiting
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present Wi...
MAE defined as: 1. All-cause death, 2. Myocardial infarction, 3. Stroke, 4. Need for non-elective cardiovascular surgery, 5. Worsening of heart-failure requiring mechanical circulatory support for more than 24 ...
Recruiting
ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System
Shunt implant safety: proportion of patients in the APTURE shunt group without any serious device or procedure-related (CEC adjudicated) complications (i.e., Major Adverse Cardiovascular, Cerebrovascular, and Renal Events [MACCRE]...
Recruiting
Levothyroxine Supplementation for Heart Transplant Recipients
Measured using the vasoactive-inotropic score (VIS) scale. VIS calculation: dopamine dose (μg/kg/min) + dobutamine dose (μg/kg/min) + 100 × epinephrine dose (μg/kg/min) + 10 × milrinone dose (μg/kg/min) + 10 000 × vasopressin dos...
Recruiting
Support services
Plan your visit
What to Bring
- Echocardiogram results from within last 6 months on CD, if available
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes
Related clinics
Our research initiatives
-
UCSF Division of Cardiology Research
Researchers at the UCSF Division of Cardiology investigate all aspects of heart disorders, from how disease develops to who is most at risk, with an emphasis on translating key findings into more effective care.